This study evaluated efficacy and safety of an innovative dry powder inhaler (DPI–Sandoz)
vs Seretide™ Accuhaler™(GSK) containing 50 μg salmeterol and 100 μg fluticasone per …

Methods: This comparative study, conducted in a population of 279 patients aged 12–65
years with GINA guideline-defined moderate-to-severe persistent asthma was undertaken …

Background and objective: Salmeterol and fluticasone propionate are well established in the
treatment of childhood asthma, and their combination is effective in children aged 4–11 …

The aim of this study was to compare the efficacy and safety in children of salmeterol (50 μg
twice daily) plus fluticasone propionate (100 μg twice daily) when delivered together via a …

Objective The aim of this study was to compare the preference, efficacy and tolerability of
Easyhaler®, a metered-dose, dry powder inhaler, with a pressurised metered-dose inhaler …

Background: Many patients with persistent asthma need both long-acting bronchodilators
and inhaled corticosteroids for optimal asthma control. Objective: Our purpose was to …

Background: A novel, inhalation-driven, multidose dry powder inhaler (MDPI) that does not
require coordination of actuation with inhalation has been developed. Objective: To evaluate …

Background: Inhaled corticosteroids are increasingly being used to treat mild-to-moderate
asthma in children. However, data regarding therapy with this class of compounds …

Background: Guideline-defined asthma control can be achieved and maintained in patients
by treatment with fluticasone propionate–salmeterol (FP-Sal). Objective: To compare the …

Background: New inhalation devices with improved lung delivery may allow the use of lower
salmeterol doses for treatment of asthma. Objective: To determine the dose of salmeterol …